Company intelligence / Profile preview

Biological Industries

Kibbutz Beit Haemek, Israelbioind.com ↗

Ownership: Private
Development stage: Commercial

Overview

Biological Industries does not conduct clinical trials or have clinical results as it supplies reagents and technologies to support life science research and biomanufacturing. Its products are widely used in academic and industrial settings globally.

Modalities: Cell therapy (enabling technology via cell culture media)Biologic (enabling technology for biologics manufacturing)Stem cell therapy (supporting with specialized media)Small molecule (supporting research and manufacturing with reagents/media)Recombinant protein (media for recombinant protein production)
Industry: Non-Drug Biotech

Partnerships

Sartorius Group partnership/acquisitioncollaborations with academic researchers/universities worldwide

Beyond the preview

Go deeper on Biological Industries.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Industries.